Inhibrx Biosciences (INBX) Interest & Investment Income (2023 - 2025)

Inhibrx Biosciences (INBX) has 3 years of Interest & Investment Income data on file, last reported at $1.3 million in Q4 2025.

• On a quarterly basis, Interest & Investment Income fell 34.45% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $7.5 million, a 31.0% decrease from a year earlier, with the FY2025 full-year figure at $7.5 million, down 31.0% from the prior year.
• Interest & Investment Income for Q4 2025 stood at $1.3 million, down from $1.8 million in the prior quarter.
• Over the last five years, Interest & Investment Income for INBX reached as high as $4.7 million in Q4 2023 and fell as low as $1.3 million in Q4 2025.
• Historically, Interest & Investment Income has averaged $2.5 million across 3 years, with a median of $2.3 million in 2025.
• On a YoY basis, Interest & Investment Income climbed as much as 24.44% in 2024 and fell as far as 57.35% in 2024.
• Year by year, Interest & Investment Income stood at $4.7 million in 2023, then slumped by 57.35% to $2.0 million in 2024, then tumbled by 34.45% to $1.3 million in 2025.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $1.3 million in Q4 2025, $1.8 million in Q3 2025, and $2.1 million in Q2 2025.